Trial Profile
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Mar 2010
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Procter & Gamble
- 30 Mar 2010 New trial record